文献速递生殖医学

硫嘌呤与男性生育力及父源性暴露子代关联的系统评价与荟萃分析

The associations of thiopurines with male fertility and paternally exposed offspring: a systematic review and meta-analysis.
PubMed 文献 · Hum Reprod Update · 2018-01-01

该系统评价与荟萃分析汇总动物与人类研究,评估硫嘌呤暴露对男性生育力及子代安全的影响。共纳入28项研究(含14项人类观察性研究),其中6项进入荟萃分析。人类研究中硫嘌呤治疗与睾丸功能或精液质量无明显受损关联;父源性硫嘌呤暴露子代先天异常风险未显著升高(合并OR 1.32,95%CI 0.75–2.34)。

要点

  • 啮齿类动物中硫嘌呤在2–20倍人等效剂量下对生殖细胞有不良影响。
  • 83例多种基础疾病男性中,硫嘌呤治疗与睾丸功能或精液质量受损无明显关联。
  • 父源性硫嘌呤暴露子代先天异常风险未显著升高(合并OR 1.32,95%CI 0.75–2.34)。

核心结论

  • 硫嘌呤在啮齿类动物中具有精子毒性作用。
  • 人类总体数据有限且来自把握度不足的研究,因此就硫嘌呤对精子发生或父源性暴露子代的可能影响尚不能得出结论。
  • 需要更大规模的流行病学试验评估硫嘌呤对男性生育力及子代的安全性,以便为希望生育的硫嘌呤治疗男性提供充分咨询。

研究设计与样本

  • 系统评价与荟萃分析,检索MEDLINE和EMBASE数据库,截至2017年5月发表的英文文献。
  • 检索未限于人类受试者,也未限于某种疾病或状况。
  • 共纳入28项研究,其中14项为人类观察性研究,6项纳入荟萃分析。
  • 采用GRADE指南评估纳入文章的证据质量。

主要发现

  • 在多种啮齿类动物中,硫嘌呤在2至20倍人等效剂量下对生殖细胞产生不良影响。
  • 在83例患有多种基础疾病的男性中,硫嘌呤治疗与睾丸功能或精液质量受损无明显关联。
  • 全部研究共描述975例子代中53例先天异常(5.4%,背景患病率为3%),可能由父源性硫嘌呤暴露所致。
  • 与无父源性硫嘌呤暴露的子代(4.7%)相比,先天异常风险未显著升高(合并OR 1.32,95%CI 0.75–2.34)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 人类总体数据有限且来自把握度不足的研究。
  • 就硫嘌呤对精子发生或父源性暴露子代的可能影响尚不能得出结论。
  • 需要更大规模的流行病学试验评估硫嘌呤对男性生育力及子代的安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thiopurines are widely used immunosuppressive agents. In high dosages, they inhibit the purine synthesis and are considered to be possibly harmful to spermatogenesis, and subsequently to men's fertility and their offspring. However, the clear association between thiopurine exposure and male fertility and reproduction safety, if any, is still poorly understood. OBJECTIVE AND RATIONALE: The aim of this review was to systematically summarize and meta-analyse the available data, derived from animal and human studies, regarding the influence of thiopurine exposure on fertility and conception safety in men and their offspring. SEARCH METHODS: A systematic literature search of the MEDLINE and EMBASE databases was performed using a combination of relevant terms related to 'thiopurines', 'fertility', 'conception', 'reproduction', 'semen quality' and 'birth outcome', combined with 'male', 'men', 'father' and 'paternal'. The search was not restricted exclusively to human subjects, neither to a type of disease or condition, to gather all available studies with regards to this topic. All published articles on thiopurines and male fertility, written in English and published until May 2017, were screened for eligibility. The GRADE guidelines were used to assess the quality of evidence of the included articles. OUTCOMES: A total of 28 studies (including 14 observational studies in humans) were included in this review and six of these were included in the meta-analysis. In various rodents, thiopurines adversely affected the germ cells (in administered doses of 2 to 20 times the human equivalent dose). In human studies, thiopurine therapy was not evidently associated with impaired testicular function or semen quality in 83 men with a variety of underlying diseases. In total, 53 out of 975 offspring with congenital anomalies (5.4%, the background prevalence is 3%), possibly as a result of paternal thiopurine exposure, were described in all studies together. The risk of congenital anomalies was not significantly increased when compared with offspring without paternal thiopurine exposure (4.7%) (pooled odds ratio 1.32, 95% confidence interval 0.75, 2.34). WIDER IMPLICATIONS: Thiopurines have spermatotoxic effects in rodents. In humans, overall data are limited and derived from underpowered studies, and therefore not conclusive with regards to the possible effects of thiopurines on spermatogenesis or paternally exposed offspring. Larger, epidemiological trials evaluating the safety of thiopurines to men's fertility and their offspring are mandatory to adequately counsel thiopurine treated men who wish to conceive.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Simsek M, Lambalk CB, Wilschut JA, et al. The associations of thiopurines with male fertility and paternally exposed offspring: a systematic review and meta-analysis. Hum Reprod Update. 2018. PMID: 29190351. doi:10.1093/humupd/dmx034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。